Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Snook

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Toxins|September 16, 2017
The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current ReportTrevor R Baybutt, Allison A Aka, Adam E Snook
The Journal of Investigative Dermatology|January 15, 2019
Adenovirus-Mediated ABCC6 Gene Therapy for Heritable Ectopic Mineralization DisordersJianhe Huang, Adam E Snook, Jouni Uitto, et al.
Toxins|April 15, 2020
Talkin' Toxins: From Coley's to Modern Cancer ImmunotherapyRobert D Carlson, John C Flickinger, Adam E Snook
Expert Opinion on Drug Discovery|January 21, 2021
From leptin to lasers: the past and present of mouse models of obesityJoshua R Barton, Adam E Snook, Scott A Waldman
Immunologic Research|November 1, 2011
GUCY2C-targeted cancer immunotherapy: past, present and futureAdam E Snook, Michael S Magee, Scott A Waldman
Expert Opinion on Biological Therapy|May 12, 2021
The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remissionJessica Kopenhaver, Madison Crutcher, Scott A Waldman, et al.
Discovery Medicine|June 4, 2013
Colorectal cancer immunotherapyBo Xiang, Adam E Snook, Michael S Magee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Derivation and fluidity of acutely induced dysfunctional CD8+ T cellsGabriela Plesa, Adam E Snook, Scott A Waldman, et al.
Toxins|September 13, 2017
ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in MicePeng Li, Jieru E Lin, Adam E Snook, et al.
Human Gene Therapy Methods|December 2, 2016
Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper EpitopeAdam E Snook, Trevor R Baybutt, Terry Hyslop, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Toxins|September 16, 2017
The Heat-Stable Enterotoxin Receptor, Guanylyl Cyclase C, as a Pharmacological Target in Colorectal Cancer Immunotherapy: A Bench-to-Bedside Current ReportTrevor R Baybutt, Allison A Aka, Adam E Snook
The Journal of Investigative Dermatology|January 15, 2019
Adenovirus-Mediated ABCC6 Gene Therapy for Heritable Ectopic Mineralization DisordersJianhe Huang, Adam E Snook, Jouni Uitto, et al.
Toxins|April 15, 2020
Talkin' Toxins: From Coley's to Modern Cancer ImmunotherapyRobert D Carlson, John C Flickinger, Adam E Snook
Expert Opinion on Drug Discovery|January 21, 2021
From leptin to lasers: the past and present of mouse models of obesityJoshua R Barton, Adam E Snook, Scott A Waldman
Immunologic Research|November 1, 2011
GUCY2C-targeted cancer immunotherapy: past, present and futureAdam E Snook, Michael S Magee, Scott A Waldman
Expert Opinion on Biological Therapy|May 12, 2021
The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remissionJessica Kopenhaver, Madison Crutcher, Scott A Waldman, et al.
Discovery Medicine|June 4, 2013
Colorectal cancer immunotherapyBo Xiang, Adam E Snook, Michael S Magee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
Derivation and fluidity of acutely induced dysfunctional CD8+ T cellsGabriela Plesa, Adam E Snook, Scott A Waldman, et al.
Toxins|September 13, 2017
ST-Producing E. coli Oppose Carcinogen-Induced Colorectal Tumorigenesis in MicePeng Li, Jieru E Lin, Adam E Snook, et al.
Human Gene Therapy Methods|December 2, 2016
Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper EpitopeAdam E Snook, Trevor R Baybutt, Terry Hyslop, et al.
Pageof 10